Join
Live feed
·
INSIDERFilingvia Quantisnow
Day One Biopharmaceuticals Inc. logo

CHIEF EXECUTIVE OFFICER Bender Jeremy converted options into 31,686 shares and sold $87,385 worth of shares (13,964 units at $6.26), increasing direct ownership by 14% to 145,737 units (SEC Form 4)

ByQuantisnow·Wall Street's wire, on your screen.
DAWN· Day One Biopharmaceuticals Inc.
Health Care
Original source

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track DAWN (Day One Biopharmaceuticals Inc.) and more on Quantisnow.